Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Alnylam Says FDA Accepted NDA For Vutrisiran For Treatment Of Polyneuropathy Of Hereditary ATTR Amyloidosis


RTTNews | Jun 24, 2021 07:04AM EDT

07:04 Thursday, June 24, 2021 (RTTNews) - Alnylam Says FDA Accepted NDA For Vutrisiran For Treatment Of Polyneuropathy Of Hereditary ATTR Amyloidosis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC